These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 688420)

  • 1. [Effect of ornithine-ketoglutarate on provoked hyperammonaemia in patients with cirrhosis of the liver (author's transl)].
    Blahíková L; Horký J; Pechar J; Vidlaková M; Zvolánková K; Vosmík J; Marecková O
    Cesk Gastroenterol Vyz; 1978 Jun; 32(4):262-7. PubMed ID: 688420
    [No Abstract]   [Full Text] [Related]  

  • 2. [Contribution to the treatment of portal systemic encephalopathy (author's transl)].
    Blahníková L; Horký J; Pechar J; Honzák R; Vosmík J
    Cesk Gastroenterol Vyz; 1978 Dec; 32(8):486-93. PubMed ID: 737756
    [No Abstract]   [Full Text] [Related]  

  • 3. [Action of ornighine alpha-ketoglutarate on hyperammoniemia in the cirrhotic patient].
    Michel H; Ogé P; Bertrand L
    Presse Med (1893); 1971 Apr; 79(19):867-8. PubMed ID: 5576498
    [No Abstract]   [Full Text] [Related]  

  • 4. [Influence of ornithin-alpha-ketoglutaric acid on fatmetabolism in patients with cirrhosis of the liver (author's transl)].
    Leinweber W; Goldberg P; Erb W
    Med Klin; 1976 Jun; 71(24):1043-6. PubMed ID: 934001
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Therapy of experimental and clinical hyperammonaemia with ornithine-alpha-ketoglutarate].
    Szám I; Szentner J; Hegedüs-Wein I; Vass A; Szilárd T
    Wien Med Wochenschr; 1974 May; 124(20):319-25. PubMed ID: 4829691
    [No Abstract]   [Full Text] [Related]  

  • 6. [Clinical trial of alpha ornithine ketoglutarate].
    Linquette M; Fossati P; Hubschman B
    Lille Med; 1969 Apr; 14():Suppl 3:512-5. PubMed ID: 5376446
    [No Abstract]   [Full Text] [Related]  

  • 7. [1 (+) ornithine alpha ketoglutarate in hepatic encephalopathy].
    Paris J; Merveille P; Molimard R
    Presse Med (1893); 1970 Jun; 78(30):1367-8. PubMed ID: 5421555
    [No Abstract]   [Full Text] [Related]  

  • 8. [Correction by L-dopa of neurologic manifestations of a chronic portocaval encephalopathy].
    Girard PF; Trillet M; Kopp N
    Rev Neurol (Paris); 1972 Nov; 127(5):560-3. PubMed ID: 4668744
    [No Abstract]   [Full Text] [Related]  

  • 9. Ornicetil on encephalopathy. Effect of ornicetil (ornithine alpha-ketoglutarate) on encephalopathy in patients with acute and chronic liver disease.
    Chainuvati T; Plengvanit U; Viranuvatti V
    Acta Hepatogastroenterol (Stuttg); 1977 Dec; 24(6):434-9. PubMed ID: 602619
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Changes of plasma amino acids in cirrhotics treated with ornithine salts].
    Molimard R; Charpentier C; Lemonnier F
    Ann Nutr Metab; 1982; 26(1):25-36. PubMed ID: 7073242
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Hyperammoniemia and its treatment].
    Szám I
    Orv Hetil; 1973 Oct; 114(43):2581-9. PubMed ID: 4585544
    [No Abstract]   [Full Text] [Related]  

  • 12. [Present-day therapy of hepatic encephalopathy (author's transl)].
    Imler M
    MMW Munch Med Wochenschr; 1976 Dec; 118(52-53):1685-94. PubMed ID: 827698
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Current problems in the treatment of hepatic cirrhosis].
    Oancea R
    Rev Med Interna Neurol Psihiatr Neurochir Dermatovenerol Med Interna; 1981; 33(4):303-10. PubMed ID: 6173910
    [No Abstract]   [Full Text] [Related]  

  • 14. [On the diagnosis of imminent bleeding from esophageal varices (author's transl)].
    Bungert HJ
    Leber Magen Darm; 1973 Dec; 3(6):242-8. PubMed ID: 4544843
    [No Abstract]   [Full Text] [Related]  

  • 15. [Treatment of hepatic comas by ornithine alpha-ketoglutarate].
    Tête R; Paliard P; Vachon A
    Rev Lyon Med; 1966 Apr; 15(8):371-8. PubMed ID: 5942225
    [No Abstract]   [Full Text] [Related]  

  • 16. [Rare sources of gastrointestinal bleeding in liver cirrhosis with portal hypertension (author's transl)].
    Rau RM; Krause F
    Leber Magen Darm; 1973 Dec; 3(6):240-1. PubMed ID: 4544842
    [No Abstract]   [Full Text] [Related]  

  • 17. [Effect of arginine ketoglutarate on the detoxifying capacity of the liver in cirrhosis of the liver (author's transl)].
    Müting D; Horback L
    MMW Munch Med Wochenschr; 1977 Apr; 119(16):535-8. PubMed ID: 405572
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [On the therapy of liver diseases with ornithine aspartate].
    Melzer H; Weber D; Wotzka R
    Med Klin; 1969; 64(35):1541-4. PubMed ID: 5354488
    [No Abstract]   [Full Text] [Related]  

  • 19. [Hepatic blood flow, portal hypertension and liver failure in patients with alcoholic cirrhosis (author's transl)].
    Lebrec D; Sicot C; Benhamou JP
    Arch Fr Mal App Dig; 1973 Sep; 62(6):465-71. PubMed ID: 4779228
    [No Abstract]   [Full Text] [Related]  

  • 20. [On the effect of neomycin on blood ammonia, free amino acids and free phenols in serum and urine in liver cirrhosis].
    Müting D; Reikowski J; Reikowski H
    Med Welt; 1968 May; 19():1235-9. PubMed ID: 5728824
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.